Capsovision, INC Form 4 insider transactions

Eliyahou Harari, a 10% owner of CapsoVision, Inc, purchased 61,068 shares of common stock on July 17, 2026 for $6.73 per share.

Eliyahou Harari, a Director and 10% owner of CapsoVision, Inc., acquired 81,300 shares of common stock on July 8, 2026, for $6.09 per share.

Eliyahou Harari, a Director at CapsoVision, Inc., acquired 13,850 shares of common stock on June 26, 2026, for $7.35 per share.

Director Joanne Imperial of CapsoVision, Inc. reported the acquisition of 2,022 shares of common stock following the vesting of Restricted Stock Units.

Joanne Imperial, a Director at CapsoVision, Inc., reported a sale of 1,200 shares of common stock on June 8, 2026.

CapsoVision, Inc. reports that Director Tsai Chen Lung acquired 2,022 shares of common stock through the vesting of Restricted Stock Units.

Hui Ying Kuo, a Director at CapsoVision, Inc., acquired 2,022 shares of common stock through the vesting of Restricted Stock Units.

CapsoVision, Inc. reports a transaction where Director Wen-Herng Henry King acquired 2,022 shares of common stock.

Director Michele Harari reported a transaction involving the acquisition of 2,022 shares of CapsoVision, Inc. common stock.

Director Julia Gouw acquired 2,022 shares of CapsoVision, Inc. common stock through the vesting of Restricted Stock Units.

Kang-Huai Wang, Director and Officer of CapsoVision, Inc., reported the acquisition of stock options on June 1, 2026.

David Michael Garcia, Sr. VP of Finance at CapsoVision, Inc., reported the acquisition of stock options on June 1, 2026, with vesting scheduled through June 1, 2030.

Douglas Atkinson, Head of Global Sales at CapsoVision, Inc., acquired 158,078 stock options with an exercise price of $6.90, vesting over several years.

Douglas Atkinson, Head of Global Sales at CapsoVision, Inc., acquired a significant number of company shares through stock option exercises on May 4th and 5th, 2026.

CapsoVision Director Tsai Chen Lung acquired 4,045 Restricted Stock Units, scheduled to vest in two tranches in 2026.

CapsoVision Director Hui Ying Kuo received an award of 4,045 Restricted Stock Units, aligning her interests with shareholders through future vesting.

CapsoVision Director Wen-Herng Henry King was granted 4,045 Restricted Stock Units, vesting in two tranches in 2026.

CapsoVision Director Joanne Imperial received a grant of 4,045 Restricted Stock Units, vesting in two tranches in 2026.

CapsoVision Director Michele Harari received a grant of 4,045 Restricted Stock Units, aligning her interests with shareholders.

CapsoVision, Inc. Director Julia S. Gouw was granted 4,045 Restricted Stock Units, vesting in two tranches in 2026.

CapsoVision Director Tsai Chen Lung amended a Form 4 to report an omitted purchase of 20 common shares at $4.17.

CapsoVision Director Michele Harari reported the acquisition of 2,887 common shares through the vesting of Restricted Stock Units, increasing direct beneficial ownership to 59,043 shares.

CapsoVision Director Julia S. Gouw is set to acquire 2,887 shares of common stock through the vesting of Restricted Stock Units on December 31, 2025.

CapsoVision Director Joanne Carol Imperial acquired 2,887 shares of common stock through the vesting of Restricted Stock Units on December 31, 2025.

CapsoVision Director Wen-Herng Henry King acquired 2,887 shares of common stock through the conversion of Restricted Stock Units.

CapsoVision Director Hui Ying Kuo increased direct beneficial ownership by 2,887 common shares through the scheduled vesting of Restricted Stock Units.

CapsoVision Director Tsai Chen Lung acquired 2,887 shares of common stock through the vesting of Restricted Stock Units.

CapsoVision, Inc. granted 165,000 stock options to Senior VP of Finance David Michael Garcia with an exercise price of $4.78, vesting over four years.

CapsoVision Director Chen Lung Tsai was granted 2,887 Restricted Stock Units, scheduled to vest on December 31, 2025.

CapsoVision Director Hui Ying Kuo was granted 2,887 Restricted Stock Units, aligning her interests with shareholders, with vesting scheduled for December 31, 2025.